You are here: Home » 2026 » March » Archives for 2nd

Bitget and Obside Partner to Launch Live AI Trading Arena for Copy Trading

VICTORIA, Seychelles, March 01, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), today announced a partnership with Obside, bringing the AI Trading Arena to Bitget through copy trading. Developed by Obside, the AI Trading Arena is a live environment where advanced AI models trade real markets autonomously using real-time data. The collaboration makes Obside’s AI traders available exclusively for copy trading on Bitget Futures.

The AI Trading Arena has been operating for over three months as a transparent, real-time benchmark for AI-driven trading performance. Through the partnership, Bitget users can copy AI traders that have already been tested through real market conditions, including volatility and drawdowns. Select AI traders in the Arena have delivered net performance exceeding 70 percent over multiple months, while maintaining controlled risk profiles. Access to copy trading was opened only after sufficient live trading history was established, reflecting a structured approach to user protection and transparency.

“AI trading is moving beyond simulation and into live market environments,” said Gracy Chen, CEO of Bitget. “The AI Trading Arena offers users a way to follow AI-driven strategies with observable track records, operating under real conditions. This partnership allows Bitget users to engage with AI trading in a way that is transparent and grounded in live performance.”

Copy trading of Obside’s AI traders is available exclusively on Bitget Futures, initially covering Bitcoin (BTCUSDT), Gold (XAUUSDT), and Nvidia (NVDAUSDT). The selected assets reflect a deliberate focus on liquidity, market depth, and varied market dynamics, allowing users to observe AI behavior across different asset classes.

“The Arena was built to evaluate how AI performs when exposed to real markets, not historical data,” said Benjamin Sultan, Co-founder of Obside and former trader at a hedge fund. “Partnering with Bitget allows these live AI traders to be accessed by a broader audience, while preserving the transparency and structure that define the Arena.”

The partnership reflects Bitget’s continued expansion of intelligent trading infrastructure within the broader UEX framework. The convergence of AI, multi-asset access, and transparent execution continues to shape how traders engage with global markets. By combining Bitget’s copy trading ecosystem with Obside’s live AI Trading Arena, the collaboration introduces a new category of market participation, where AI-driven strategies can be observed and followed in real time.

About Bitget

Bitget is the world's largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 100+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships with LALIGA and MotoGP™. Aligned with its global impact strategy, Bitget has joined hands with UNICEF to support blockchain education for 1.1 million people by 2027. Bitget currently leads the tokenized TradFi market, offering the industry's lowest fees and the highest liquidity across 150 regions worldwide.

For more information, visit: Website | Twitter | Telegram | LinkedIn | Discord

For media inquiries, please contact: [email protected]

Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0b20abba-5c9f-4760-9a9a-edaf6972871c


GLOBENEWSWIRE (Distribution ID 1001167509)

SynaXG Proves the Art of the Possible with Fully Software-Defined AI-RAN on NVIDIA AI Aerial

BARCELONA, Spain and SINGAPORE, March 02, 2026 (GLOBE NEWSWIRE) — SynaXG today announced major technical breakthroughs in AI-native radio access networks, demonstrating concurrent operation of 5G FR1, 5G FR2 and AI workloads on NVIDIA AI-RAN platform with real-time, policy-driven GPU orchestration. The results confirm that software-defined, AI-native RAN can deliver carrier-grade performance and continuous 24×7 operation, ready for commercial deployment.

SynaXG achieved carrier-grade 5G FR1 performance on a single NVIDIA GH200 platform. The system simultaneously operated 20 x 100MHz 5G NR cells, delivering more than 36Gbps of aggregated throughput with sub-10 millisecond latency, while supporting up to 1,200 connected user equipment per cell. These results validate that a fully software-defined AI-RAN running on accelerated computing infrastructure can match the performance of best-in-class commercial 5G deployments, while enabling AI workloads to run concurrently on the same shared platform without compromising network KPIs.

SynaXG also achieved the world’s first carrier-grade FR2 virtualized RAN implementation running concurrently with FR1 and AI workloads on a shared GPU platform. The system delivered high throughput with end-to-end latency as low as 5 milliseconds, meeting the performance requirements for dense urban and enterprise deployments. This milestone demonstrates that millimetre-wave RAN can be realized as a fully software-defined workload on accelerated infrastructure without compromising carrier-grade KPIs.

SynaXG’s real-time orchestration software dynamically allocates, and switches Multi-Instance GPU (MIG) partitions based on live RAN and AI key performance indicators. GPU resources are continuously rebalanced across FR1 for coverage, FR2 for capacity and AI workloads without service interruption, enabling deterministic RAN performance while maximizing infrastructure utilization.

The AI-RAN system operated continuously, 24 hours a day, 7 days a week, under sustained load, validating the stability, scalability and operational resilience required for carrier environments. The results confirm that NVIDIA GPU-accelerated AI-RAN can maintain predictable performance while adapting dynamically to changing traffic conditions and workload demand.

SynaXG’s AI-RAN platform is built on hardware and software stack leveraging NVIDIA AI Aerial platforms, enabling a software-defined, AI-native architecture that supports deterministic network performance alongside AI processing on shared GPU infrastructure.

Looking ahead, SynaXG is extending its AI-RAN platform to additional NVIDIA platforms, including NVIDIA DGX Spark, demonstrating the portability of its software-defined architecture. This write once, run anywhere approach across NVIDIA CUDA-based platforms accelerates innovation cycles and simplifies deployment at speed that has never been seen with traditional approaches.

In parallel, SynaXG continues to advance AI-for-RAN capabilities focused on network optimization and automation, spectral and energy efficiency, ISAC, distributed MIMO, ICIC, etc. SynaXG has been working with partners on AI agents that analyse real-time network conditions and service demand and take actions to enhance performance, energy efficiency and operational simplicity in AI-native networks.

“With the recent industry-leading breakthroughs, SynaXG has demonstrated that AI-RAN can deliver carrier-grade FR1 and FR2 performance with continuous 24×7 operation on shared NVIDIA AI infrastructure,” said Xin Huang, CEO of SynaXG. “Our software-defined approach enables operators and enterprises to deploy scalable, AI-native networks and are ready for commercial deployment.”

“Software-defined architecture is key to the next generation of wireless networks. SynaXG’s benchmark 5G performance on NVIDIA AI-RAN platform proves that operators and enterprises can achieve the flexibility and agility of cloud-native computing while maintaining carrier-grade throughput and performance per watt, required for commercial 5G services”, said Soma Velayutham, VP of AI and Telecoms, NVIDIA.

SynaXG will showcase these AI-RAN breakthroughs as part of the AI-RAN Alliance Working Group 2 demonstrations at AI-RAN Alliance booth Hall 2, 2E45 and at the SynaXG booth at Hall 5, 5F21 Mobile World Congress 2026 in Barcelona.

About SynaXG

SynaXG is a Singapore-based technology company pioneering AI-native radio access networks (AI-RAN). Its unified software platform integrates 5G RAN and AI capabilities on shared commercial hardware, enabling operators, hyperscalers and enterprises to deploy high-performance, energy-efficient, and monetizable AI-driven networks. SynaXG works closely with global ecosystem partners across silicon, cloud, RAN and AI to accelerate the transition toward 5G-Advanced and 6G architectures.
For more information, visit www.synaxg.com

Watch the video accompanying this announcement on YouTube.
For additional context, see NVIDIA’s AI-RAN on its corporate blog.

Media contact: [email protected]

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e0e6c93a-fb23-4f53-9edb-f495916f1c41 


GLOBENEWSWIRE (Distribution ID 9663633)

VTGN DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTGN

NEW YORK, March 01, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) between April 1, 2024 and December 16, 2025, both dates inclusive (the “Class Period”), of the important March 16, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Vistagen common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Vistagen class action, go to https://rosenlegal.com/submit-form/?case_id=50827 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 16, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants provided investors with material information concerning Vistagen’s plan to develop and commercialize its drug fasedienol, an investigational pherine candidate in development for the acute treatment of social anxiety disorder (SAD). Defendants’ statements included, among other things, Vistagen’s positive assertions of fasedienol’s future trial success based on the prior positive results associated with the PALISADE-2 clinical trial, in addition to notable enhancements and operational changes made to the execution of the PALISADE-3 clinical trial supported a strong likelihood of Phase 3 success and positioned it as a confirmatory study.

According to the lawsuit, defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning its Phase 3 PALISADE-3 trial study of fasedienol. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Vistagen class action, go to https://rosenlegal.com/submit-form/?case_id=50827 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9663024)